Símbolo: IBM

IBM

Software Tecnologia Serviços de tecnologia da informação

Preço 257.81

Rec. Comprar Potencial 65 Risco 40 Atualizado 2026-10-31

Site oficial

Impacto da previsão

limitado

Alvo +2.8% preenchimento do alvo 97.3%

Reação D5 -0.18% · D10 pendente confiança do mercado

Impacto Potencial 0 · Risco 0 válido até 2026-11-21

Acompanhar no portfólio

Gráfico de preço

Recomendação da IA Previsão do analista Evento de calendário Sinal positivo Sinal negativo Neutro / atualização Manter / informativo B Minha compra S Minha venda

Descrição

Empresa e modelo de negócios

A IBM é uma empresa multinacional de tecnologia que oferece uma variedade de produtos e serviços, incluindo computação em nuvem, inteligência artificial, análise de dados e soluções de software empresarial. Seus principais segmentos de negócios incluem Software em Nuvem e Cognitivo, Serviços Empresariais Globais, Serviços de Tecnologia Global e Sistemas. A empresa gera receita principalmente a partir de software e serviços, com um foco significativo em soluções baseadas em nuvem e impulsionadas por IA.

Perfil de investimento

O perfil de investimento da IBM está mais alinhado com investidores equilibrados devido ao seu rendimento de dividendos estável e presença de mercado estabelecida. A empresa oferece potencial para crescimento moderado enquanto proporciona renda por meio de dividendos, tornando-a adequada para aqueles que buscam uma combinação de valorização de capital e geração de renda.

Categoria: Software Setor: Tecnologia Indústria: Serviços de tecnologia da informação Estilo de investimento: Equilibrado Horizonte: Médio prazo Tipo de empresa: Blue Chip Tipo de empresa: Líder de mercado Experiência: Básico

Métricas fundamentais (experimental) Atualizado: 2026-10-31

EPS (TTM) — lucro por ação dos últimos 12 meses, $: 11.90
Receita QoQ — crescimento da receita trimestre contra trimestre: -0.3%
Surpresa de EPS: 3.5%
Volatilidade 20d: 1.4%
Dividend yield: 3.3%
última data ex-dividendo: 2026-11-10

Mudanças na recomendação da IA

Data	Antes	Depois	Motivo
2026-10-25	Manter	Comprar	Strong recent performance, but mixed long-term momentum.
2026-10-15	Comprar	Manter	Weak momentum and mixed fundamentals suggest caution.
2026-10-13	Manter	Comprar	Stable fundamentals, but mixed momentum signals present uncertainty.
2026-09-30	Comprar	Manter	Weak momentum and mixed fundamentals suggest caution.
2026-09-23	Vender	Comprar	Stable fundamentals, but mixed momentum signals.
2026-09-17	Comprar	Vender	Weak momentum and high risk limit upside potential.
2026-09-10	Manter	Comprar	Stable fundamentals, but mixed momentum signals present risks.
2026-08-15	Comprar	Manter	Weak momentum and high risk offset potential growth.
2026-08-08	Manter	Comprar	Solid fundamentals, but mixed momentum signals present uncertainty.
2026-07-29	Vender	Manter	Mixed momentum; cautious due to recent performance decline.
2026-07-15	Manter	Vender	Weak fundamentals and negative momentum signal high risk.
2026-07-02	Vender	Manter	Mixed performance; fundamentals show weakness and high risk.
2026-06-19	Manter	Vender	Weak fundamentals and negative momentum raise significant concerns.
2026-06-09	Comprar	Manter	Weak fundamentals and negative momentum raise concerns.
2026-06-03	Manter	Comprar	Strong recent performance and positive EPS surprise.
2026-05-16	Vender	Manter	Weak fundamentals and negative momentum signal high risk.
2026-05-08	—	Vender	Weak fundamentals and negative momentum raise concerns.
2026-05-03	Manter	Vender	Компания демонстрирует негативные тренды по доходам и цене акций в последние месяцы, однако дивидендная доходность остается привлекательной, что может удерживать интерес инвесторов.
2026-04-25	Comprar	Manter	Компания IBM демонстрирует сильный рост выручки, но последние падения акций и высокая волатильность вызывают опасения. Рекомендуется удерживать акции до более ясных сигналов о восстановлении.
2026-04-21	Vender	Comprar	Компания показывает положительную динамику выручки и EPS, однако недавнее снижение на длительных горизонтах вызывает опасения. Рекомендуется удерживать акции до получения более ясных сигналов о восстановлении.
2026-04-13	Manter	Vender	Компания IBM демонстрирует снижение цен на акции в краткосрочной перспективе, однако имеет стабильный рост выручки и дивидендную доходность. Рекомендуется удерживать акции до более ясных сигналов о восстановлении.
2026-03-29	Manter	Vender	Компания IBM демонстрирует сильный рост выручки, но значительное снижение цены акций за последние месяцы указывает на высокие риски. Рекомендуется удерживать акции до более ясных сигналов о восстановлении.
2026-03-05	Vender	Manter	Компания IBM показывает положительную динамику в краткосрочной перспективе, однако долгосрочные показатели и снижение за последние 60 дней вызывают опасения. Дивидендная доходность также привлекательна, что делает акцию
2026-02-24	Manter	Vender	Акции IBM показывают значительное снижение в краткосрочной перспективе и высокую волатильность, что указывает на повышенные риски для инвесторов. Учитывая текущие показатели и негативные тренды, рекомендуется продавать.
2026-02-04	Comprar	Manter	Компания показывает смешанные результаты, с недавним падением цены акций, но с положительной динамикой за 120 дней. Рекомендуется удерживать акции до получения ясности в финансовых показателях.
2026-01-30	Manter	Comprar	Компания показывает положительную динамику на коротких и средних временных интервалах, что может свидетельствовать о восстановлении интереса инвесторов. Однако отсутствие данных по EPS и дивидендам требует осторожности.

Previsões de analistas

Data	Analista	Action	Alvo	Preço na época
2026-10-22	BMO Capital	Preço-alvo elevado	230 → 265	248.85
2026-10-22	Truist Financial	Preço-alvo elevado	240 → 260	246.575
2026-10-22	Stifel Nicolaus	Preço-alvo elevado	— → 260	251.46
2026-10-22	Susquehanna	Preço-alvo elevado	253 → 256	251.46
2026-10-22	Goldman Sachs	Preço-alvo elevado	270 → 300	251.46
2026-10-22	UBS	Preço-alvo elevado	236 → 243	251.46
2026-10-22	Robert W. Baird	Preço-alvo elevado	230 → 260	251.46
2026-10-22	Morgan Stanley	Preço-alvo elevado	238 → 240	251.46
2026-10-22	Barclays	Preço-alvo elevado	262 → 277	251.46
2026-10-22	Jefferies	Preço-alvo elevado	270 → 280	251.46
2026-10-09	Truist Financial	Atualizar	— → 240	226.61
2026-08-31	Susquehanna	Preço-alvo elevado	225 → 235	233.51
2026-07-24	Susquehanna	Preço-alvo reduzido	303 → 225	211.99
2026-07-23	BMO Capital	Preço-alvo reduzido	270 → 230	203.62
2026-07-23	Goldman Sachs	Preço-alvo reduzido	335 → 270	205.77
2026-07-23	Morgan Stanley	Preço-alvo reduzido	293 → 190	205.77
2026-07-23	Barclays	Preço-alvo reduzido	288 → 262	205.77
2026-07-21	Robert W. Baird	Atualizar	— → 230	210.5
2026-07-21	RBC Capital	Preço-alvo reduzido	— → 270	210.655
2026-07-21	Barclays	Preço-alvo reduzido	350 → 288	213
2026-07-21	Jefferies	Preço-alvo reduzido	320 → 260	213
2026-07-20	Stifel Nicolaus	Preço-alvo reduzido	— → 235	212.67
2026-07-16	HSBC	Preço-alvo reduzido	191 → 175	214.05
2026-07-16	Argus Research	Preço-alvo reduzido	360 → 280	210.5
2026-07-14	Oppenheimer	Preço-alvo elevado	— → 350	220.02
2026-07-14	Morgan Stanley	Preço-alvo elevado	267 → 293	290.23
2026-07-14	HSBC	Rating rebaixado	— → 191	290.23
2026-07-10	Susquehanna	Atualizar	— → 303	295.3
2026-06-23	Morgan Stanley	Preço-alvo elevado	225 → 267	252.22
2026-06-02	Wedbush	Preço-alvo elevado	320 → 350	320.42
2026-06-01	Barclays	Atualizar	— → 350	297.8
2026-05-22	Stifel Nicolaus	Atualizar	— → 290	252.97
2026-04-28	HSBC	Rating elevado	— → 231	228.05
2026-04-23	Morgan Stanley	Preço-alvo elevado	215 → 225	226.525
2026-04-23	BMO Capital	Preço-alvo reduzido	290 → 270	224.71
2026-04-23	Wedbush	Preço-alvo reduzido	340 → 320	251.86
2026-04-20	Jefferies	Preço-alvo reduzido	370 → 320	253.47
2026-04-17	RBC Capital	Preço-alvo reduzido	361 → 330	253.25
2026-04-16	Oppenheimer	Preço-alvo reduzido	380 → 320	247.365
2026-04-14	Morgan Stanley	Preço-alvo reduzido	247 → 215	237.82
2026-01-30	Argus Research	Preço-alvo elevado	340 → 360	304.06

Notícias Página 5 de 5

Analysts Barclays initiate coverage of IBM (IBM) with overweight rating and $350 target price, citing quantum computing potential

06/01/2026, 08:33 AM investing rating_growth Analysts: analysts, Barclays ai IBM

Barclays has initiated coverage of IBM with an overweight rating, highlighting the company's significant investment in quantum computing, which could lead to substantial stock gains for investors.

Software Stocks Surge as Nvidia CEO Jensen Huang Unveils New N1X Chip at Computex

06/01/2026, 03:31 AM growth software Nvidia Nebius IBM Hewlett Packard Enterprise

Nvidia's announcement of a new chip designed for personal computers has led to significant gains in software stocks, indicating strong investor confidence in the technology sector.

IBM CEO Arvind Krishna Highlights Anthropic’s Mythos as Key Driver for $5 Billion Cybersecurity Investment

05/28/2026, 11:32 AM economy announcement software ai JPMorgan Chase Goldman Sachs IBM Morgan Stanley Bank of America

IBM's CEO Arvind Krishna highlighted the significance of Anthropic's Mythos in the company's $5 billion investment in a new cybersecurity initiative aimed at addressing vulnerabilities in open-source software, which has already attracted major U.S. banks as early adopters.

Analysts expect upside for IBM (IBM) following significant government funding boost

05/22/2026, 08:33 AM investing forecast Analysts: analysts ai software IBM

IBM's stock surged over 12.5% following a $1 billion federal grant aimed at bolstering the U.S. quantum computing supply chain, marking a significant turnaround for the company amid a challenging year.

U.S. Stocks Reach New Heights as Iran Considers Peace Proposal Amid Ongoing Tensions

05/21/2026, 07:32 PM review finance ai Microsoft IBM

U.S. stock markets are experiencing a positive trend, with major indexes achieving significant weekly gains, largely driven by investor optimism regarding potential peace negotiations between the U.S. and Iran. This development is crucial as it may influence market stability and oil prices.

Traders Anticipate IBM (IBM) as a Leading Quantum Computing Investment Following $1 Billion U.S. Government Grant

05/21/2026, 12:33 PM business growth software IBM

Traders are increasingly optimistic about IBM following the announcement of a $1 billion grant from the U.S. Commerce Department to support quantum computing, leading to a surge in options trading for the stock.